These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6988263)

  • 1. Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment.
    Kosaka K; Kuzuya T; Akanuma Y; Hagura R
    Diabetologia; 1980 Jan; 18(1):23-8. PubMed ID: 6988263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin secretory responses in patients with glucose intolerance due to extra-pancreatic causes. Comparison with idiopathic diabetes mellitus.
    Kosaka K; Kuzuya T; Hagura R; Akanuma Y; Kanazawa Y
    Endocrinol Jpn; 1981 Aug; 28(4):487-98. PubMed ID: 6763894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the discontinuation of long-term sulfonylurea treatment on blood glucose and insulin secretion in noninsulin-dependent diabetes mellitus.
    Sumi S; Ichihara K; Nonaka K; Tarui S
    Endocrinol Jpn; 1982 Feb; 29(1):41-7. PubMed ID: 7049684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance in patients with insulin independent diabetes mellitus: partial amelioration by the sulfonylurea glipizide.
    Lebovitz H; Feinglos MN
    Adv Exp Med Biol; 1979; 119():371-9. PubMed ID: 495293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison on sulphonylurea and insulin treatment on lipid levels in maturity-onset diabetic men and women.
    Berry EM; Bar-on H
    Isr J Med Sci; 1981 May; 17(5):384-7. PubMed ID: 7021470
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of treatment with diet alone on oral glucose-tolerance test and plasma sugar and insulin levels in patients with maturity-onset diabetes mellitus.
    Doar JW; Wilde CE; Thompson ME; Sewell PF
    Lancet; 1975 Jun; 1(7919):1263-6. PubMed ID: 48896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations.
    Fineberg SE; Schneider SH
    Diabetologia; 1980 Jan; 18(1):49-54. PubMed ID: 6988265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfonylurea treatment of insulin-independent diabetes mellitus.
    Feinglos MN; Lebovitz HE
    Metabolism; 1980 May; 29(5):488-94. PubMed ID: 6990184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term improvement in insulin response with gliclazide treatment.
    Bodansky HJ; Medback S; Cudworth AG; Rees LH; de Silva RS
    Diabete Metab; 1982 Dec; 8(4):319-22. PubMed ID: 6761187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose tolerance, plasma insulin and lipids in diabetic subjects before and after treatment with a new sulfonylurea compounds, Ro 6-4563.
    Berchtold P; Björntorp P; Gustafson A; Jonsson A; Fagerberg SE
    Eur J Clin Pharmacol; 1971 Dec; 4(1):22-8. PubMed ID: 5151389
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucagon response to arginine after treatment of diabetes mellitus.
    Ohneda A; Ishii S; Horigome K; Yamagata S
    Diabetes; 1975 Sep; 24(9):811-9. PubMed ID: 1158041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics.
    Lisch HJ; Sailer S
    Diabetologia; 1981 Feb; 20(2):118-22. PubMed ID: 6781964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese non-insulin-dependent diabetic subjects.
    Laakso M; Uusitupa M; Takala J; Majander H; Reijonen T; Penttilä I
    Metabolism; 1988 Nov; 37(11):1092-100. PubMed ID: 3054433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus.
    Kosaka K; Kuzuya T; Hagura R; Yoshinaga H
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S109-19. PubMed ID: 8894494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human C-peptide in normal and diabetic subjects.
    Heding LG; Rasmussen SM
    Diabetologia; 1975 Jun; 11(3):201-6. PubMed ID: 1149953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic control in 107 maturity onset diabetic out patients (author's transl)].
    Charitanski D; Blouquit Y; Papoz L; Soria J; Rosa J; Tchobroutsky G
    Nouv Presse Med; 1980 Feb; 9(9):585-9. PubMed ID: 6987621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose tolerance and insulin response to glucose load before and after enzyme inducing therapy in subjects with glucose intolerance and patients with NIDDM having hyperinsulinemia or relative insulin deficiency.
    Sotaniemi EA; Karvonen I
    Diabetes Res; 1989 Jul; 11(3):131-9. PubMed ID: 2697484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of bran on glucose kinetics and plasma insulin in non-insulin-dependent diabetes mellitus.
    Hall SE; Bolton TM; Hetenyi G
    Diabetes Care; 1980; 3(4):520-5. PubMed ID: 6257458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of type 2 (non-insulin-dependent) diabetic patients with diet alone.
    Wales JK
    Diabetologia; 1982 Sep; 23(3):240-5. PubMed ID: 6751904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.